These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21498820)

  • 1. Lung-resident mesenchymal stromal cells. A new player in post-transplant bronchiolitis obliterans syndrome?
    Martinu T; Palmer SM; Ortiz LA
    Am J Respir Crit Care Med; 2011 Apr; 183(8):968-70. PubMed ID: 21498820
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung transplantation. Bronchiolitis obliterans syndrome.
    Corris PA
    Chest Surg Clin N Am; 2003 Aug; 13(3):543-57. PubMed ID: 13678312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-lung transplantation bronchiolitis obliterans].
    Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
    Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchiolitis obliterans syndrome leads to a functional deterioration of the acinus post lung transplant.
    Thompson BR; Hodgson YM; Kotsimbos T; Liakakos P; Ellis MJ; Snell GI; Verbanck S
    Thorax; 2014 May; 69(5):487-8. PubMed ID: 24212890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchiolitis obliterans: pathogenesis, prevention, and management.
    Paradis I
    Am J Med Sci; 1998 Mar; 315(3):161-78. PubMed ID: 9519929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyspnea, Cough, and Abnormal Thoracic Imaging after Lung Transplantation.
    Walker CM; Hobbs SB; Carter BW; Chung JH
    Ann Am Thorac Soc; 2016 Jan; 13(1):134-6. PubMed ID: 26730869
    [No Abstract]   [Full Text] [Related]  

  • 8. Lung transplantation and bronchiolitis obliterans syndrome: are two lungs better than one?
    Levine SM
    Chest; 2002 Oct; 122(4):1112-4. PubMed ID: 12377826
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.
    Badri L; Murray S; Liu LX; Walker NM; Flint A; Wadhwa A; Chan KM; Toews GB; Pinsky DJ; Martinez FJ; Lama VN
    Am J Respir Crit Care Med; 2011 Apr; 183(8):1062-70. PubMed ID: 21169468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.
    Gauthier JM; Ruiz-Pérez D; Li W; Hachem RR; Puri V; Gelman AE; Kreisel D
    Transplantation; 2018 Sep; 102(9):1459-1466. PubMed ID: 29683998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplant bronchiolitis obliterans: Deja vu.
    Anthonisen NR
    Can Respir J; 2003 Mar; 10(2):66-8. PubMed ID: 12687024
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary graft dysfunction.
    Lee JC; Christie JD
    Proc Am Thorac Soc; 2009 Jan; 6(1):39-46. PubMed ID: 19131529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant bronchiolitis obliterans syndrome. Where have we been and where are we going?
    Dauber JH
    Chest; 1996 Apr; 109(4):857-9. PubMed ID: 8635356
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obliterative bronchiolitis in the lung transplant recipient. A powerful foe.
    Smith-Seiler DA; Iacono AT
    Adv Nurse Pract; 2004 Apr; 12(4):69-74. PubMed ID: 15101139
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome.
    Ikonen T; Kivisaari L; Harjula AL; Lehtola A; Heikkilä L; Kinnula VL; Kyösola K; Savola J; Sipponen J; Verkkala K; Mattila SP
    J Heart Lung Transplant; 1996 Jun; 15(6):587-95. PubMed ID: 8803756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broncho-bronchiolitis obliterans after living-donor lung transplantation: a unique manifestation of chronic allograft rejection.
    Sakurai H; Morishima Y; Itoguchi N; Ohtsuka S; Yamadori I; Oto T; Ishii Y; Sakamoto T; Noguchi M; Hizawa N
    Transplantation; 2013 Aug; 96(4):e29-30. PubMed ID: 23958888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.